Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Insulet Corp (NQ: PODD ) 205.15 +0.73 (+0.36%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Insulet Corp < Previous 1 2 3 4 Next > Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System September 20, 2022 From Insulet Corporation Via Business Wire Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes August 22, 2022 From Insulet Corporation Via Business Wire Insulet to Present at Upcoming Investor Conferences August 05, 2022 From Insulet Corporation Via Business Wire Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1) August 04, 2022 From Insulet Corporation Via Business Wire Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System August 01, 2022 From Insulet Corporation Via Business Wire The Healthcare Companies Fighting the World’s Biggest Killers July 13, 2022 Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the... Via FinancialNewsMedia Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022 June 30, 2022 From Insulet Corporation Via Business Wire Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years June 03, 2022 From Insulet Corporation Via Business Wire Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference June 02, 2022 From Insulet Corporation Via Business Wire Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia June 01, 2022 From Insulet Corporation Via Business Wire Insulet Announces CEO Transition May 05, 2022 From Insulet Corporation Via Business Wire Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year May 05, 2022 From Insulet Corporation Via Business Wire Insulet’s 2021 Sustainability Report Reveals Progress on Strategy to Deliver Growth with Purpose May 02, 2022 From Insulet Corporation Via Business Wire Insulet Presents New Omnipod® 5 System Data for Type 1 and Type 2 Diabetes April 27, 2022 From Insulet Corporation Via Business Wire Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022 April 07, 2022 From Insulet Corporation Via Business Wire Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year February 23, 2022 From Insulet Corporation Via Business Wire Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons February 17, 2022 From Insulet Corporation Via Business Wire Insulet to Present at Upcoming Investor Conferences February 16, 2022 From Insulet Corporation Via Business Wire Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine February 07, 2022 From Insulet Corporation Via Business Wire Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control January 28, 2022 From Insulet Corporation Via Business Wire CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 January 12, 2022 From Insulet Corporation Via Business Wire Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021 January 12, 2022 From Insulet Corporation Via Business Wire Insulet to Present at Nasdaq’s 45th Investor Conference November 24, 2021 From Insulet Corporation Via Business Wire Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year November 04, 2021 From Insulet Corporation Via Business Wire Insulet Honors Diabetes Awareness with Global Activities and Events November 01, 2021 From Insulet Corporation Via Business Wire Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford October 18, 2021 From Insulet Corporation Via Business Wire Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use September 30, 2021 From Insulet Corporation Via Business Wire Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021 September 29, 2021 From Insulet Corporation Via Business Wire Insulet to Present at Upcoming Investor Conferences August 26, 2021 From Insulet Corporation Via Business Wire Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States August 16, 2021 From Insulet Corporation Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.